GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
Abstract Background: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the alpha galactosidase A gene (GLA) that lead to the enzymatic deficiency of alpha galactosidase (α-Gal A), resulting in the accumulation of globotriaosylceramide (Gb3) and globotriaosylsphing...
Main Authors: | Ândrea Virgínia Chaves-Markman, Manuel Markman, Eveline Barros Calado, Ricardo Flores Pires, Marcelo Antônio Oliveira Santos-Veloso, Catarina Maria Fonseca Pereira, Andréa Bezerra de Melo da Silveira Lordsleem, Sandro Gonçalves de Lima, Brivaldo Markman Filho, Dinaldo Cavalcanti de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
|
Series: | Arquivos Brasileiros de Cardiologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000700077&lng=en&tlng=en |
Similar Items
-
Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
by: Marcelo Imbroinise Bittencourt -
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
by: Ravi Vijapurapu, et al.
Published: (2022-01-01) -
Il coinvolgimento cardiaco nella malattia di Fabry
by: Maurizio Pieroni
Published: (2017-09-01) -
The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study
by: Hasan Ali Barman, et al.
Published: (2019-11-01) -
Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
by: David Zemánek, et al.
Published: (2022-12-01)